Navigation Links
Experienced Drug Development and Partnering CEO Takes the Helm at Tolera
Date:12/3/2013

span> and his BSc. honors in Biochemistry and Applied Molecular Biology from the University of Manchester, England.

"Having completed a successful Phase 2 renal transplantation study for its lead product candidate, TOL101, Tolera is now poised to carefully consider its strategic options, evaluate the needs of prospective partners, and advance this novel therapeutic approach towards a market that appears ripe for the entry of an advantageous induction agent," commented Palmer.  "Tolera also has a significant opportunity to advance its broader T-cell targeting therapeutic platform, especially with respect to autoimmune disease and cancer.  Effective partnering will be the key to this endeavor."

About Tolera Therapeutics   
Tolera Therapeutics is a biotechnology company focused on developing and commercializing a highly specific, T-cell antagonist, monoclonal antibody technology (anti-TCR) with application potential across a broad spectrum of T-cell mediated diseases, such as transplant rejection, autoimmune disease and cancer.  Its lead product candidate, TOL101, has to date successfully completed clinical testing through Ph2 and is ready to commence advanced stage clinical testing having received approval of a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) for a Phase 3 clinical trial comparing TOL101 to Thymoglobulin.  Primary investors in the company include Triathlon Medical Venture Partners, Hopen Life Science Ventures, the SWMF Life Science Fund, and the Michigan Economic Development Corporation.  Additional information concerning the company and its technology can be found on its website www.tolera.com.

Media Contact: 
Jason Rando  
Tiberend Strategic Advisors, Inc. 
212.375.2665 
jrando@tiberend.com   '/>"/>

SOURCE Tolera Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
2. ERT Acquires invivodata to Establish the Industrys Most Experienced Provider of Clinical Outcome Assessment Solutions
3. RxAlly Announces Addition Of Experienced Corporate Counsel Tom OGrady To The Companys Leadership Team
4. Safe in Common Offers Experienced Advice for U.K.s Review of Needlestick Safety Regulations
5. Survey of Oncologists Reveals 98.9% of Physicians Experienced Cancer Drug Shortages in Last 12 Months
6. Experienced Surgeon Vs. FDA-Approved Robot
7. Primary Efficacy and Safety Findings from Phase 3 Study of Janssens Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
8. Simeprevir Administered Once Daily as Part of Combination Therapy Demonstrates Sustained Virologic Response in Treatment-Naive and Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients
9. Rapid Fire Marketing Funds Development of Second Generation Vapor Inhaler
10. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
11. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... On Thursday, July 10, 2014, the NASDAQ ... Average finished the day 0.42% lower at 16,915.07, and the ... broad based as eight out of ten sectors ended the ... ended the day at 711.88, down 0.02%, while the index ... initiated coverage on the following equities: Covidien PLC (NYSE: ...
(Date:7/11/2014)... 11, 2014 Research and Markets ( ... "Immunoprotein Diagnostic Testing Market - Forecasts to ... of 6% and is expected to be valued ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... has been segmented according to immunoprotein types which ...
(Date:7/11/2014)... , July 11, 2014 ... visitors to Safety & Health Expo 2014 ... the move to London ... management attending exhibition.     ... http://photos.prnewswire.com/prnh/20140711/696892-a )      ...
Breaking Medicine Technology:Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 2UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 3UK's Flagship Health & Safety Event Has Successful Inaugural Year in London 4
... May Reduce Inflammation After,Menopause; Weight-Loss Surgery Improves Beta ... 2007 /PRNewswire/ -- People who have,type 2 diabetes ... age, though researchers are uncertain what accounts for ... new study being,published in the April issue of ...
... announced results from a study published in the ... of a novel,new drug, CSL-111, to acutely raise ... plaque in the,coronary arteries of patients with a ... advised that the Effect of Reconstituted HDL on,Atherosclerosis ...
Cached Medicine Technology:Diabetes Linked to Higher Parkinson's Risk 2Diabetes Linked to Higher Parkinson's Risk 3Diabetes Linked to Higher Parkinson's Risk 4CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 2CSL Therapy That Mimics “Good” Cholesterol May Reduce,Plaque Volume in Coronary Arteries 3
(Date:7/12/2014)... If you make exercise fun, you,ll eat less after your ... were led on a 1.4-mile walk and were either told ... The participants were given lunch after the walk, and those ... percent more chocolate pudding for dessert than those who were ... 46 adults were given mid-afternoon snacks after their walk. Those ...
(Date:7/12/2014)... “After my mom’s stroke, she loss the use ... loss the use of his left side. Eating became a difficult ... help people like them enjoy eating again,” said an inventor, from ... PATRICIA CAROL HALL PLATE (P C H PLATE). , The PATRICIA ... way to eat for individuals who suffer from stroke, experience tremors ...
(Date:7/12/2014)... Beverly Hills, CA (PRWEB) July 12, 2014 ... reason why are bodies can readily absorb the nutrients in ... into tiny particles that are small enough to be absorbed ... the DZ10 team, a lack of enzymes in regular food ... DZ10 is a product that was started by Michelle DelPresto, ...
(Date:7/12/2014)... (PRWEB) July 12, 2014 As reported in ... Institute of Standards and Technology), the June 25th, 2014 Supreme ... electronic discovery world. It was also met with ... depending on whether it was seen from an individual privacy ... much is fact, there is now precedent which will require ...
(Date:7/12/2014)... Texas (PRWEB) July 12, 2014 ... Breastfeeding Made Simple as a valuable new resource for ... roughly two-thirds of American women work away from their ... sources touting the benefits of breastfeeding, but often feel ... to nurse their babies. With its evidence-based insights, and ...
Breaking Medicine News(10 mins):Health News:Make Exercise Fun, Eat Less Afterwards 2Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 2Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 3Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 4Health News:Mobile Device Forensics Guidelines Play Key Role in Supreme Court’s Smartphone Evidence Warrant Decision 5Health News:Praeclarus Press Announces the Release of Working and Breastfeeding Made Simple by Nancy Mohrbacher, A Much Needed Resource For Today's Working Mothers 2
... to Raise $260,000 for ORBIS Children,s Eye Care Project ... ... Nyan and Lehka Pendyala, ages 8 and 6,will launch a kid-inspired and ... childhood blindness. Their,ultimate goal is to raise $260,000 for a specialized pediatric ...
... Human Health Effects of Fruit and Vegetables (FAV) is ... from October 9 till 13 in Houston, TX. ... & bridge the communication gap between the agricultural sciences, ... is unique since scientists, students, industry, commodity groups and ...
... 9 Nurse Savvy Research Group is,an exciting ... is an online medical information service established to,provide ... to which,doctors they would choose for a variety ... The data gathered for the website will be,obtained ...
... ... Saudi Arabia, SOMERSET, N.J., Oct. ... AWT International, Inc.,has opened new sales offices in Saudi Arabia. ... healthcare industry. The Company has hired 2 highly experienced executives ...
... Two UT Southwestern Medical Center researchers a distinguished ... elected to the Institute of Medicine, a component of ... Luis Parada, professor and chairman of developmental biology, and ... among 65 new national members and four foreign associates ...
... DIEGO, Oct. 9 Many Americans are obsessed with,staying ... about being,mentally fit. More Americans are becoming aware of ... where knowledge, intelligence, and quick,wits are rewarded. Being mentally ... effectively train your brain have been lacking,until recently. ...
Cached Medicine News:Health News:Elementary School Students to Launch 'Kids for Sight' Campaign, to Inspire Other Kids to Pay it Forward 2Health News:Elementary School Students to Launch 'Kids for Sight' Campaign, to Inspire Other Kids to Pay it Forward 3Health News:Nursesavvy.com Promoting Quality Healthcare for Everyone 2Health News:AWT, Inc. Continues Rapid Expansion in Middle East 2Health News:AWT, Inc. Continues Rapid Expansion in Middle East 3Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 2Health News:2 UT Southwestern researchers elected to National Academy of Sciences' Institute of Medicine 3Health News:Online Game from BrainGrade Can Raise Brain I.Q. 2
... Surgical's Breakthrough in Battery Powered Orthopedic Systems., ... revolutionary new addition to the Hall® Surgical ... Battery System is the first and only ... the market. It is a full-function orthopedic ...
... the new large power ... new handpieces function as ... instruments, offering the ultimate ... versatility the industry has ...
... OBIs proprietary PolyGraft® material technology which ... that is both biologically friendly and ... of polylactide-co-glycolide, calcium sulfate and polyglycolide ... fabricated into products such as granules, ...
... Release System is a technological breakthrough in ... a minimally-invasive approach, provides significant patient benefits. ... of the wrist,creates an entry for the ... a standard video camera system, provides a ...
Medicine Products: